# mRNA Sequencing of Limbal Epithelial Cells and mRNA/miRNA Profiling of Limbal Stromal Cells in PAX6-Related Congenital Aniridia

**Authors:** Tanja Stachon, Shweta Suiwal, Maryam Amini, Marta Corton, Fabian Norbert Fries, Berthold Seitz, Nicole Ludwig, Shusruto Rishik, Andreas Keller, Nóra Szentmáry

PMC · DOI: 10.3390/cells15040340 · 2026-02-13

## TL;DR

This study identifies gene and microRNA changes in eye cells from congenital aniridia patients, highlighting inflammation and metabolism issues that could lead to new treatments.

## Contribution

The study provides the first comprehensive mRNA and miRNA profiles of limbal epithelial and stromal cells in congenital aniridia.

## Key findings

- AN-LECs showed 188 differentially expressed genes linked to inflammation and interferon responses.
- AN-LSCs had 3001 DEGs, mostly related to mitochondrial and metabolic functions.
- 48 deregulated miRNAs were found in AN-LSCs, suggesting roles in disease mechanisms.

## Abstract

The dysfunction of limbal epithelial cells (LECs) and limbal stromal cells (LSCs) in congenital aniridia remains incompletely understood. We aimed to analyze mRNA expression profiles of primary human LECs and LSCs, as well as microRNA (miRNA) expression in LSCs, from patients with congenital aniridia (AN-LECs and AN-LSCs). mRNA sequencing of primary human LECs and mRNA and miRNA sequencing of LSCs were performed from patients with aniridia and healthy controls. Gene ontology and pathway analyses were used to evaluate biological processes, cellular components, and molecular functions. Selected deregulated mRNAs and miRNAs were validated by quantitative real-time PCR (RT-qPCR). A total of 188 differentially expressed genes (DEGs) were identified in AN-LECs, and 3001 DEGs in AN-LSCs. In AN-LECs, the top hub genes were associated with inflammatory and interferon-related responses. In contrast, AN-LSCs showed predominant deregulation of mitochondrial and metabolic genes. Pathway analysis revealed involvement of inflammation-related pathways in AN-LECs and metabolic pathways in AN-LSCs. Additionally, 48 deregulated miRNAs were identified in AN-LSCs. This study provides comprehensive mRNA profiles of LECs and LSCs and miRNA profiles of LSCs in congenital aniridia. The findings emphasize the importance of LSC influence and offer insights into molecular mechanisms underlying aniridia-associated keratopathy (AAK), supporting future research and potential therapeutic target identification.

## Linked entities

- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** CXCL11 (C-X-C motif chemokine ligand 11) [NCBI Gene 6373] {aka H174, I-TAC, IP-9, IP9, SCYB11, SCYB9B}, C2 (complement C2) [NCBI Gene 717] {aka ARMD14, CO2}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, CXCL5 (C-X-C motif chemokine ligand 5) [NCBI Gene 6374] {aka ENA-78, SCYB5}, IFIT1 (interferon induced protein with tetratricopeptide repeats 1) [NCBI Gene 3434] {aka C56, G10P1, IFI-56, IFI-56K, IFI56, IFIT-1}, MIR326 (microRNA 326) [NCBI Gene 442900] {aka MIRN326, hsa-mir-326, mir-326}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, SLC26A8 (solute carrier family 26 member 8) [NCBI Gene 116369] {aka AZON, SPGF3, TAT1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, RSAD2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 91543] {aka SAND, cig33, cig5, vig1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, FOXE1 (forkhead box E1) [NCBI Gene 2304] {aka BAMLAZ, FKHL15, FOXE2, HFKH4, HFKL5, NMTC4}, OAS1 (2'-5'-oligoadenylate synthetase 1) [NCBI Gene 4938] {aka E18/E16, IFI-4, IMD100, OIAS, OIASI}, ND2 (NADH dehydrogenase subunit 2) [NCBI Gene 4536] {aka MTND2}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, ELOA2 (elongin A2) [NCBI Gene 51224] {aka HsT832, TCEB3B, TCEB3L}, NRN1 (neuritin 1) [NCBI Gene 51299] {aka NRN, dJ380B8.2}, ND6 (NADH dehydrogenase subunit 6) [NCBI Gene 4541] {aka MTND6}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, TBP (TATA-box binding protein) [NCBI Gene 6908] {aka GTF2D, GTF2D1, HDL4, SCA17, TBP1, TFIID}, IFIT3 (interferon induced protein with tetratricopeptide repeats 3) [NCBI Gene 3437] {aka CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60}, NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) [NCBI Gene 4714] {aka ASHI, CI-ASHI, MC1DN32}, MX1 (MX dynamin like GTPase 1) [NCBI Gene 4599] {aka IFI-78K, IFI78, MX, MxA, lncMX1-215}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CRABP2 (cellular retinoic acid binding protein 2) [NCBI Gene 1382] {aka CRABP-II, RBP6}, TNXB (tenascin XB) [NCBI Gene 7148] {aka EDS3, EDSCLL, EDSCLL1, HXBL, TENX, TN-X}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, ANKRD29 (ankyrin repeat domain 29) [NCBI Gene 147463], ISG15 (ISG15 ubiquitin like modifier) [NCBI Gene 9636] {aka G1P2, IFI15, IMD38, IP17, UCRP, hUCRP}, IVL (involucrin) [NCBI Gene 3713], MUC22 (mucin 22) [NCBI Gene 100507679] {aka PBMUCL1}, PEX6 (peroxisomal biogenesis factor 6) [NCBI Gene 5190] {aka HMLR2, PAF-2, PAF2, PBD4A, PDB4B, PXAAA1}, FGL2 (fibrinogen like 2) [NCBI Gene 10875] {aka T49, pT49}, KRT12 (keratin 12) [NCBI Gene 3859] {aka K12, MECD1}, IL20RA (interleukin 20 receptor subunit alpha) [NCBI Gene 53832] {aka CRF2-8, IL-20R-alpha, IL-20R1, IL-20RA}, RELN (reelin) [NCBI Gene 5649] {aka ETL7, LIS2, PRO1598, RL}, IRX6 (iroquois homeobox 6) [NCBI Gene 79190] {aka IRX-3, IRX7, IRXB3}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SHE (Src homology 2 domain containing E) [NCBI Gene 126669], IFIT2 (interferon induced protein with tetratricopeptide repeats 2) [NCBI Gene 3433] {aka G10P2, GARG-39, IFI-54, IFI-54K, IFI54, IFIT-2}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, miR-127-3p [NCBI Gene 100302165], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, ND4L (NADH dehydrogenase subunit 4L) [NCBI Gene 4539] {aka MTND4L}, ND4 (NADH dehydrogenase subunit 4) [NCBI Gene 4538] {aka MTND4}, SIX3 (SIX homeobox 3) [NCBI Gene 6496] {aka HPE2}, NDUFV2 (NADH:ubiquinone oxidoreductase core subunit V2) [NCBI Gene 4729] {aka CI-24k, MC1DN7}, CPHXL (cytoplasmic polyadenylated homeobox like) [NCBI Gene 105371346] {aka CPHXL1}, MAP3K9 (mitogen-activated protein kinase kinase kinase 9) [NCBI Gene 4293] {aka MEKK9, MLK1, PRKE1}, WNT2 (Wnt family member 2) [NCBI Gene 7472] {aka INT1L1, IRP}, VNN2 (vanin 2) [NCBI Gene 8875] {aka FOAP-4, GPI-80}, PLA2G2A (phospholipase A2 group IIA) [NCBI Gene 5320] {aka MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1}, ND5 (NADH dehydrogenase subunit 5) [NCBI Gene 4540] {aka MTND5}, APOD (apolipoprotein D) [NCBI Gene 347], BRINP1 (BMP/retinoic acid inducible neural specific 1) [NCBI Gene 1620] {aka DBC1, DBCCR1, FAM5A}
- **Diseases:** acute myocardial infarction (MESH:D009203), Leber's hereditary optic neuropathy (MESH:D029242), dry eye disease (MESH:D015352), AN-LECs (MESH:D009375), associated keratopathy (MESH:C562399), absence (MESH:D004832), hepatocellular carcinoma (MESH:D006528), focal (MESH:D005490), breast cancer (MESH:D001943), iris (MESH:D007499), uveal melanoma (MESH:C536494), glaucoma (MESH:D005901), tumor (MESH:D009369), injury to (MESH:D014947), panocular disease (MESH:D004194), neurodegenerative diseases (MESH:D019636), inflammation (MESH:D007249), Mitochondrial dysfunction (MESH:D028361), optic atrophy (MESH:D009896), Corneal Diseases (MESH:D003316), Aniridia (MESH:D015783), AN-LSCs (MESH:D000092423)
- **Chemicals:** fatty acids (MESH:D005227), F12 medium (-), all-trans retinoic acid (MESH:D014212), LPS (MESH:D008070), EDTA (MESH:D004492), F12 (MESH:C007782), CaCl2 (MESH:D002122), Retinol (MESH:D014801)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** umbilical vein endothelial cells — Homo sapiens (Human), Finite cell line (CVCL_3722), HFLS — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_AP75), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939772/full.md

---
Source: https://tomesphere.com/paper/PMC12939772